Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Philip Rowe

1PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 11, 2021
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.

Keiichi Fujiwara, Hiroyuki Fujiwara, Hiroyuki Yoshida

Pageof 1

Frequent Collaborators

1 joint publications

Keiichi Fujiwara

1 joint publications

Hiroyuki Fujiwara

1 joint publications

Hiroyuki Yoshida

1 joint publications

Toyomi Satoh

1 joint publications

Kan Yonemori

1 joint publications

Shoji Nagao

1 joint publications

Takashi Matsumoto

1 joint publications

Hiroaki Kobayashi

1 joint publications

Hughes Bourgeois

1 joint publications

Philipp Harter

Frequent Collaborators

1 joint publications

Keiichi Fujiwara

1 joint publications

Hiroyuki Fujiwara

1 joint publications

Hiroyuki Yoshida

1 joint publications

Toyomi Satoh

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.6K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.6K
See more related videos